Résultats de la recherche - 5 results
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
immune responses it induces. METHODS: In this observational cohort study, peak humoral and cellular immune responses were compared 28 days after the second and third doses of the BNT162 b2 mRNA COVID-19 ...
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:
Publication Type: Peer reviewed scientific article Authors: Yana Debie; Jonas R.M. Van Audenaerde; Timon Vandamme; Lieselot Croes; Laure-Anne Teuwen; Lise Verbruggen; Greetje Vanhoutte; Elly Marcq; Lisa Verheggen; Debbie Le Blon; Bart Peeters; Maria Gooss ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
explained by socioeconomic differences in the prevalence of chronic diseases. Further research is needed to explore if this difference could be related to a lower immune response of people with certain ...
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff- study protocol description and presentation of preliminary findings on symptoms.
infections (ARI). However, little is known, about the impact of a previous or current infection on the other in terms of susceptibility, immune response, and clinical course. The aim of the “Prior Infection ...
SARS-CoV-2 prevalence, seroprevalence and seroconversion among healthcare workers in Belgium during the 2020 Covid-19 outbreak: Study protocol
Infections liées aux soins et antibiorésistance Zorginfecties en antibioticaresistentie Healthcare-associated infections and antimicrobial resistance Réponse immunitaire Immuunrespons Immune response Maladies ...